From: The healthcare costs of treating human papillomavirus-related cancers in Norway
Type of healthcare | ||||||||
---|---|---|---|---|---|---|---|---|
Cancer diagnosis | Year | Specialist carea | Primary physician care | Prescription drugs | Total healthcare cost | |||
Cost (€) | % of total healthcare cost | Cost (€) | % of total healthcare cost | Cost (€) | % of total healthcare cost | |||
Cervical cancer | 2012 | 13,521,776 | 98.49 | 207,603 | 1.51 | – | – | 13,729,379 |
2013 | 15,542,183 | 98.57 | 225,436 | 1.43 | – | – | 15,767,619 | |
2014 | 17,213,190 | 98.66 | 234,055 | 1.34 | – | – | 17,447,245 | |
Vaginal cancer | 2012 | 455,472 | 100.00 | – | – | – | – | 455,472 |
2013 | 430,787 | 100.00 | – | – | – | – | 430,787 | |
2014 | 462,786 | 100.00 | – | – | – | – | 462,786 | |
Vulvar cancer | 2012 | 3,454,485 | 100.00 | – | – | – | – | 3,454,485 |
2013 | 3,175,389 | 100.00 | 44 | 0.00 | – | – | 3,175,433 | |
2014 | 3,395,240 | 100.00 | – | – | – | – | 3,395,240 | |
Penile cancer | 2012 | 1,309,498 | 100.00 | – | – | – | – | 1,309,498 |
2013 | 1,397,461 | 100.00 | – | – | – | – | 1,397,461 | |
2014 | 1,623,327 | 100.00 | – | – | – | – | 1,623,327 | |
Anal cancer | 2012 | 4,807,059 | 99.42 | 62 | 0.00 | 27,785 | 0.57 | 4,834,906 |
2013 | 4,578,332 | 99.19 | – | – | 37,328 | 0.81 | 4,615,660 | |
2014 | 5,108,420 | 99.72 | 23 | 0.00 | 14,597 | 0.28 | 5,123,040 | |
Oropharyngeal cancer | 2012 | 11,748,410 | 100.00 | 91 | 0.00 | – | – | 11,748,501 |
2013 | 11,622,064 | 100.00 | 77 | 0.00 | – | – | 11,622,141 | |
2014 | 11,736,770 | 100.00 | – | – | – | – | 11,736,770 | |
All HPV-related cancers | 2012 | 35,296,699 | 99.34 | 207,756 | 0.59 | 27,785 | 0.08 | 35,532,240 |
2013 | 36,746,215 | 99.29 | 225,557 | 0.61 | 37,328 | 0.10 | 37,009,100 | |
2014 | 39,539,733 | 99.38 | 234,077 | 0.59 | 14,597 | 0.04 | 39,788,406 | |
Mean across 2012–2014 | 37,194,216 | 222,463 | 26,570 | 37,443,249 | ||||
Percentage increase, 2012–1014 | 12.02 | 12.67 | −47.46 | 11.98 |